Redmile Group, LLC Syros Pharmaceuticals, Inc. Transaction History

Redmile Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.26 - $4.66 $126,853 - $181,329	-38,912 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.01 - $7.48 $868,628 - $1.3 Million	-173,379 Reduced 81.67%	38,912 $212,000
Q4 2019 Feb 14, 2020	SELL	$4.52 - $10.1 $16.6 Million - $37.1 Million	-3,676,461 Reduced 94.54%	212,291 $1.47 Million
Q3 2019 Nov 14, 2019	BUY	$7.14 - $11.65 $1.92 Million - $3.13 Million	268,376 Added 7.41%	3,888,752 $40.4 Million
Q2 2019 Aug 14, 2019	BUY	$5.5 - $9.75 $10.9 Million - $19.3 Million	1,975,176 Added 120.06%	3,620,376 $33.5 Million
Q1 2019 May 15, 2019	SELL	$5.51 - $9.59 $23,902 - $41,601	-4,338 Reduced 0.26%	1,645,200 $15 Million
Q4 2018 Feb 14, 2019	SELL	$5.55 - $11.34 $36,630 - $74,844	-6,600 Reduced 0.4%	1,649,538 $9.19 Million
Q3 2018 Nov 14, 2018	BUY	$9.74 - $12.92 $242,535 - $321,720	24,901 Added 1.53%	1,656,138 $19.7 Million
Q2 2018 Aug 14, 2018	SELL	$10.16 - $13.65 $213,390 - $286,690	-21,003 Reduced 1.27%	1,631,237 $16.7 Million
Q1 2018 May 15, 2018	BUY	$9.47 - $12.98 $9.61 Million - $13.2 Million	1,015,008 Added 159.28%	1,652,240 $0
Q4 2017 Feb 14, 2018	SELL	$8.45 - $17.48 $35,380 - $73,188	-4,187 Reduced 0.65%	637,232 $6.2 Million
Q3 2017 Nov 14, 2017	BUY	$13.52 - $23.75 $8.67 Million - $15.2 Million	641,419	641,419 $9.44 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $4.86M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.